| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of F2 mRNA | affects expression | 21346803 
 | 
| C044815 | 3-keto-desogestrel | 3-keto-desogestrel promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402 
 | 
| D000255 | Adenosine Triphosphate | calmidazolium affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746 
 | 
| D000255 | Adenosine Triphosphate | F2 protein results in increased secretion of Adenosine Triphosphate | increases secretion | 2030746 
 | 
| D000255 | Adenosine Triphosphate | Fendiline affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746 
 | 
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of F2 protein | affects expression | 20106945 
 | 
| D000638 | Amiodarone | Amiodarone inhibits the reaction [F2 protein results in increased expression of and results in increased activity of F3 protein] | decreases reaction|increases activity|increases expression | 18974383 
 | 
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of F2 mRNA | affects expression | 16483693 
 | 
| D000661 | Amphetamine | Amphetamine promotes the reaction [F2 protein results in increased expression of F3 protein] | increases expression|increases reaction | 20118172 
 | 
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065 
 | 
| C031942 | argatroban | argatroban binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 15080313 16084352
 18449412
 
 | 
| D001218 | Aspartame | Aspartame analog results in decreased activity of F2 protein | decreases activity | 15572260 
 | 
| D001218 | Aspartame | Aspartame results in decreased activity of F2 protein | decreases activity | 15572260 
 | 
| C111479 | BCH 2763 | BCH 2763 results in decreased activity of F2 protein | decreases activity | 9684808 
 | 
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of F2 mRNA | increases expression | 20440473 
 | 
| C095105 | bexarotene | bexarotene results in decreased expression of F2 mRNA | decreases expression | 16648578 
 | 
| C074619 | bivalirudin | bivalirudin binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 18449412 17696810
 15155122
 15080313
 16084352
 19124943
 
 | 
| C074619 | bivalirudin | bivalirudin inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 16845256 
 | 
| C074619 | bivalirudin | bivalirudin results in decreased activity of F2 protein | decreases activity | 8456428 1290488
 19644995
 
 | 
| C074619 | bivalirudin | F2 protein results in increased cleavage of bivalirudin | increases cleavage | 1290488 
 | 
| C074619 | bivalirudin | bivalirudin inhibits the reaction [F2 protein results in increased expression of SERPINE1 mRNA] | decreases reaction|increases expression | 9125671 9579636
 
 | 
| C074619 | bivalirudin | bivalirudin inhibits the reaction [F2 protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 9579636 
 | 
| C074619 | bivalirudin | bivalirudin inhibits the reaction [F2 protein results in increased secretion of SERPINE1 protein] | decreases reaction|increases secretion | 9125671 
 | 
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [F2 protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 9579636 
 | 
| C031938 | calmidazolium | calmidazolium affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746 
 | 
| D002211 | Capsaicin | Capsaicin affects the expression of F2 protein | affects expression | 8285224 
 | 
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of F2 protein | increases activity | 12297134 
 | 
| C086276 | cerivastatin | cerivastatin inhibits the reaction [F2 protein results in decreased expression of ENTPD1 protein] | decreases expression|decreases reaction | 12067895 
 | 
| D002713 | Chlorine | Chlorine results in decreased expression of F2 mRNA | decreases expression | 18636392 
 | 
| D002713 | Chlorine | [Ozone co-treated with Chlorine] affects the expression of F2 mRNA | affects cotreatment|affects expression | 18636392 
 | 
| C055162 | clopidogrel | clopidogrel inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 17043144 
 | 
| D003474 | Curcumin | Curcumin inhibits the reaction [F2 protein results in increased expression of ITGA2B protein] | decreases reaction|increases expression | 18565277 
 | 
| D003474 | Curcumin | Curcumin inhibits the reaction [F2 protein results in increased expression of ITGB3 protein] | decreases reaction|increases expression | 18565277 
 | 
| D003474 | Curcumin | Curcumin inhibits the reaction [F2 protein results in increased expression of SELE protein] | decreases reaction|increases expression | 18565277 
 | 
| D003474 | Curcumin | Curcumin inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 18565277 
 | 
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of F2 mRNA | decreases expression | 20106945 
 | 
| D003871 | Dermatan Sulfate | [Dermatan Sulfate co-treated with SERPIND1 protein] results in decreased activity of F2 protein | affects cotreatment|decreases activity | 11805133 
 | 
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402 
 | 
| D003907 | Dexamethasone | Dexamethasone promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402 
 | 
| C023635 | dienogest | [Ethinyl Estradiol co-treated with dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [F2 protein results in increased activity of F3 protein] | decreases reaction|increases activity | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [F2 protein results in increased expression of F3 mRNA] | decreases reaction|increases expression | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [F2 protein results in increased expression of F3 protein] | decreases reaction|increases expression | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased activity of F3 protein] | affects cotreatment|decreases reaction|increases activity | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 mRNA] | affects cotreatment|decreases reaction|increases expression | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK8 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065 
 | 
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065 
 | 
| C454300 | estradiol valerate-dienogest | [Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased expression of F2 protein | affects cotreatment|increases expression | 15288212 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of F2 protein | affects cotreatment|decreases activity | 16522526 
 | 
| D004997 | Ethinyl Estradiol | [Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of F2 protein | affects cotreatment|decreases expression | 15504374 
 | 
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of F2 mRNA | affects cotreatment|decreases expression | 17942748 
 | 
| D005275 | Fendiline | Fendiline affects the reaction [F2 protein results in increased secretion of Adenosine Triphosphate] | affects reaction|increases secretion | 2030746 
 | 
| C025314 | ferric citrate | ferric citrate results in decreased activity of F2 protein | decreases activity | 6421970 
 | 
| C020748 | ferrous sulfate | ferrous sulfate results in decreased activity of F2 protein | decreases activity | 6421970 
 | 
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of F2 mRNA | decreases expression | 16709241 
 | 
| D005576 | Forskolin | Forskolin inhibits the reaction [F2 protein results in increased expression of SERPINE1 protein] | decreases reaction|increases expression | 9579636 
 | 
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of F2 protein | affects cotreatment|decreases activity | 16522526 
 | 
| C033273 | Gestodene | [Ethinyl Estradiol co-treated with Gestodene] results in decreased expression of F2 protein | affects cotreatment|decreases expression | 15504374 
 | 
| D006493 | Heparin | Heparin inhibits the reaction [F2 protein results in increased cleavage of F2R protein] | decreases reaction|increases cleavage | 19468011 
 | 
| D007501 | Iron | Iron results in decreased activity of F2 protein | decreases activity | 6421970 
 | 
| C083544 | lepirudin | lepirudin binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 15080313 18449412
 
 | 
| D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402 
 | 
| D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate promotes the reaction [F2 protein results in increased expression of F3 mRNA] | increases expression|increases reaction | 11733402 
 | 
| C109573 | melagatran | melagatran binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 16084352 
 | 
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of F2 mRNA | decreases expression | 16251485 
 | 
| D010126 | Ozone | [Ozone co-treated with Chlorine] affects the expression of F2 mRNA | affects cotreatment|affects expression | 18636392 
 | 
| D017239 | Paclitaxel | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065 
 | 
| D017239 | Paclitaxel | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased activity of F3 protein] | affects cotreatment|decreases reaction|increases activity | 19944065 
 | 
| D017239 | Paclitaxel | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 mRNA] | affects cotreatment|decreases reaction|increases expression | 19944065 
 | 
| D017239 | Paclitaxel | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein] | affects cotreatment|decreases reaction|increases expression | 19944065 
 | 
| D017239 | Paclitaxel | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK8 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065 
 | 
| D017239 | Paclitaxel | epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] | affects cotreatment|decreases reaction|increases phosphorylation | 19944065 
 | 
| D017239 | Paclitaxel | [Paclitaxel co-treated with F2 protein] affects the localization of RELA protein | affects cotreatment|affects localization | 19944065 
 | 
| D017239 | Paclitaxel | [Paclitaxel co-treated with F2 protein] results in increased activity of F3 protein | affects cotreatment|increases activity | 19944065 
 | 
| D017239 | Paclitaxel | [Paclitaxel co-treated with F2 protein] results in increased expression of F3 mRNA | affects cotreatment|increases expression | 19944065 
 | 
| D017239 | Paclitaxel | [Paclitaxel co-treated with F2 protein] results in increased expression of F3 protein | affects cotreatment|increases expression | 19944065 
 | 
| D017239 | Paclitaxel | [Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK8 protein | affects cotreatment|increases phosphorylation | 19944065 
 | 
| D017239 | Paclitaxel | [Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein | affects cotreatment|increases phosphorylation | 19944065 
 | 
| C020924 | phenylalanyl-prolyl-arginine methyl chloride | phenylalanyl-prolyl-arginine methyl chloride inhibits the reaction [F2 protein results in increased expression of FOS mRNA] | decreases reaction|increases expression | 18597608 
 | 
| C020924 | phenylalanyl-prolyl-arginine methyl chloride | phenylalanyl-prolyl-arginine methyl chloride inhibits the reaction [F2 protein results in increased expression of MYC mRNA] | decreases reaction|increases expression | 18597608 
 | 
| C060974 | phosphatidylinositol 3,4,5-triphosphate | F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate | increases abundance | 16051184 
 | 
| C060974 | phosphatidylinositol 3,4,5-triphosphate | resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate] | decreases reaction|increases abundance | 16051184 
 | 
| C060980 | phosphatidylinositol 3,4-diphosphate | F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate | increases abundance | 16051184 
 | 
| C060980 | phosphatidylinositol 3,4-diphosphate | resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate] | decreases reaction|increases abundance | 16051184 
 | 
| C037178 | phosphatidylinositol 4-phosphate | F2 protein results in increased abundance of phosphatidylinositol 4-phosphate | increases abundance | 16051184 
 | 
| C037178 | phosphatidylinositol 4-phosphate | resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 4-phosphate] | decreases reaction|increases abundance | 16051184 
 | 
| D010716 | Phosphatidylinositols | F2 protein results in increased abundance of Phosphatidylinositols | increases abundance | 16051184 
 | 
| D010716 | Phosphatidylinositols | resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositols] | decreases reaction|increases abundance | 16051184 
 | 
| D019269 | Phosphatidylinositol 4,5-Diphosphate | F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate | increases abundance | 16051184 
 | 
| D019269 | Phosphatidylinositol 4,5-Diphosphate | resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate] | decreases reaction|increases abundance | 16051184 
 | 
| D011794 | Quercetin | Quercetin inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 14628445 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4,5-triphosphate] | decreases reaction|increases abundance | 16051184 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 3,4-diphosphate] | decreases reaction|increases abundance | 16051184 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositol 4,5-Diphosphate] | decreases reaction|increases abundance | 16051184 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased abundance of phosphatidylinositol 4-phosphate] | decreases reaction|increases abundance | 16051184 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased abundance of Phosphatidylinositols] | decreases reaction|increases abundance | 16051184 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased expression of SELP protein] | decreases reaction|increases expression | 16051184 
 | 
| C059514 | resveratrol | resveratrol inhibits the reaction [F2 protein results in increased phosphorylation of PLEK protein] | decreases reaction|increases phosphorylation | 16051184 
 | 
| D019821 | Simvastatin | Simvastatin inhibits the reaction [F2 protein results in decreased expression of ENTPD1 protein] | decreases expression|decreases reaction | 12067895 
 | 
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of F2 mRNA | affects cotreatment|decreases expression | 17942748 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of F2 mRNA | increases expression | 16267337 
 | 
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of F2 mRNA | increases expression | 15644576 
 | 
| C524038 | variegin protein, Amblyomma variegatum | F2 protein results in increased cleavage of variegin protein, Amblyomma variegatum | increases cleavage | 19644995 
 | 
| C524038 | variegin protein, Amblyomma variegatum | variegin protein, Amblyomma variegatum binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 19644995 
 | 
| D014859 | Warfarin | F2 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 14656880 
 | 
| C426686 | ximelagatran | ximelagatran binds to and results in decreased activity of F2 protein | affects binding|decreases activity | 16084352 15155122
 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000014 | Abnormalities, Drug-Induced |  | Capsaicin | 6.78 | 18926900 | 
| MESH:D000014 | Abnormalities, Drug-Induced |  | Tetrachlorodibenzodioxin | 6.78 | 15322242	14514962	11752688 | 
| MESH:D000138 | Acidosis |  | Ammonium Chloride | 2.98 | 18287403 | 
| MESH:D000152 | Acne Vulgaris |  | Ethinyl Estradiol | 3.35 | 17505938 | 
| MESH:D054058 | Acute Coronary Syndrome |  | bivalirudin | 11.45 | 19804226	10629409 | 
| MESH:D054058 | Acute Coronary Syndrome |  | clopidogrel | 11.45 | 19106084 | 
| MESH:D058186 | Acute Kidney Injury |  | Capsaicin | 7.37 | 18460982 | 
| MESH:D058186 | Acute Kidney Injury |  | resveratrol | 7.37 | 16538975 | 
| MESH:D055371 | Acute Lung Injury |  | Chlorine | 3.79 | 20601635 | 
| MESH:D000230 | Adenocarcinoma |  | Benzo(a)pyrene | 5.95 | 20127859	20464547 | 
| MESH:D000230 | Adenocarcinoma |  | Ethinyl Estradiol | 5.95 | 14692618 | 
| MESH:D000230 | Adenocarcinoma |  | Fluorouracil | 5.95 | 17638652 | 
| MESH:D000236 | Adenoma |  | Benzo(a)pyrene | 5.59 | 6695378 | 
| MESH:D000236 | Adenoma |  | resveratrol | 5.59 | 15688382 | 
| MESH:D018248 | Adenoma, Liver Cell |  | Tetrachlorodibenzodioxin | 2.80 | 16835633 | 
| MESH:D019973 | Alcohol-Related Disorders |  | Curcumin | 4.49 | 17887948 | 
| MESH:D000505 | Alopecia |  | Capsaicin | 4.26 | 17569567 | 
| MESH:D019896 | alpha 1-Antitrypsin Deficiency |  | Iron | 5.07 | 16640825 | 
| MESH:D000544 | Alzheimer Disease |  | Curcumin | 8.06 | 15590663 | 
| MESH:D000544 | Alzheimer Disease |  | Iron | 8.06 | 16563566	16640825 | 
| MESH:D000544 | Alzheimer Disease |  | Ozone | 8.06 | 15513908 | 
| MESH:D000544 | Alzheimer Disease |  | resveratrol | 8.06 | 16162502	16183991 | 
| MESH:D019969 | Amphetamine-Related Disorders |  | Amphetamine | 5.47 | 16459022	15010207	18475255	16916582 | 
| MESH:D000740 | Anemia |  | Fluorouracil | 11.95 | 17963324	16511603	15504547 | 
| MESH:D000740 | Anemia |  | Iron | 11.95 | 16434484	16566752 | 
| MESH:D000740 | Anemia |  | Tetrachlorodibenzodioxin | 11.95 | 11748828 | 
| MESH:D000743 | Anemia, Hemolytic |  | Quercetin | 3.72 | 17084956 | 
| MESH:D018798 | Anemia, Iron-Deficiency |  | Iron | 4.14 | 17375513	17162259	17163184	16569441	17147795 | 
| MESH:D000755 | Anemia, Sickle Cell |  | Aspartame | 5.50 | 11372003 | 
| MESH:D000756 | Anemia, Sideroblastic |  | Iron | 4.29 | 16910769 | 
| MESH:D000787 | Angina Pectoris |  | Fendiline | 6.31 | 12088766 | 
| MESH:D000855 | Anorexia |  | Amphetamine | 4.50 | 16084549	16101753	12005258	12183048 | 
| MESH:D017544 | Aortic Aneurysm, Abdominal |  | Benzo(a)pyrene | 3.50 | 19183758 | 
| MESH:D001145 | Arrhythmias, Cardiac |  | Amiodarone | 7.55 | 20041841	18218290	18057881 | 
| MESH:D001145 | Arrhythmias, Cardiac |  | Iron | 7.55 | 16604332 | 
| MESH:D001161 | Arteriosclerosis |  | Ethinyl Estradiol | 2.90 | 11256880 | 
| MESH:D001169 | Arthritis, Experimental |  | Dexamethasone | 10.11 | 17659584 | 
| MESH:D001169 | Arthritis, Experimental |  | Ethinyl Estradiol | 10.11 | 15885639 | 
| MESH:D001169 | Arthritis, Experimental |  | resveratrol | 10.11 | 17115116 | 
| MESH:D001172 | Arthritis, Rheumatoid |  | Aspartame | 6.65 | 10777254 | 
| MESH:D001172 | Arthritis, Rheumatoid |  | Curcumin | 6.65 | 16807698 | 
| MESH:D001172 | Arthritis, Rheumatoid |  | Ozone | 6.65 | 15570426 | 
| MESH:D001249 | Asthma |  | epigallocatechin gallate | 4.61 | 16516891 | 
| MESH:D001249 | Asthma |  | Ozone | 4.61 | 16373670	17854713 | 
| MESH:D001260 | Ataxia Telangiectasia |  | Iron | 11.17 | 15336622 | 
| MESH:D001260 | Ataxia Telangiectasia |  | Quercetin | 11.17 | 15336622 | 
| MESH:D050197 | Atherosclerosis |  | Curcumin | 9.01 | 18704882 | 
| MESH:D050197 | Atherosclerosis |  | Iron | 9.01 | 16632123	16640825 | 
| MESH:D050197 | Atherosclerosis |  | resveratrol | 9.01 | 17967414	16873680 | 
| MESH:D001281 | Atrial Fibrillation |  | Amiodarone | 3.46 | 19698954	18651412 | 
| MESH:D001321 | Autistic Disorder |  | Iron | 2.87 | 17352947 | 
| MESH:D001327 | Autoimmune Diseases |  | Curcumin | 14.89 | 19761891 | 
| MESH:D001327 | Autoimmune Diseases |  | epigallocatechin gallate | 14.89 | 19761891 | 
| MESH:D001327 | Autoimmune Diseases |  | Quercetin | 14.89 | 19761891 | 
| MESH:D001424 | Bacterial Infections |  | Iron | 4.61 | 16640825 | 
| MESH:D001778 | Blood Coagulation Disorders | marker/mechanism |  |  | 17721328 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Amiodarone | 12.57 | 19483382 | 
| MESH:D001778 | Blood Coagulation Disorders |  | ferrous sulfate | 12.57 | 6421970 | 
| MESH:D001778 | Blood Coagulation Disorders |  | Tetrachlorodibenzodioxin | 12.57 | 12125929 | 
| MESH:D001836 | Body Weight Changes |  | Tetrachlorodibenzodioxin | 3.20 | 15340226 | 
| MESH:D001848 | Bone Diseases, Developmental |  | Tetrachlorodibenzodioxin | 2.37 | 15746008 | 
| MESH:D001859 | Bone Neoplasms |  | Paclitaxel | 4.03 | 15867366 | 
| MESH:D001919 | Bradycardia |  | Capsaicin | 4.48 | 18207255 | 
| MESH:D002545 | Brain Ischemia | marker/mechanism |  |  | 14753426 | 
| MESH:D002545 | Brain Ischemia |  | Capsaicin | 13.82 | 19211983 | 
| MESH:D002545 | Brain Ischemia |  | Curcumin | 13.82 | 16770732 | 
| MESH:D002545 | Brain Ischemia |  | resveratrol | 13.82 | 17600658 | 
| MESH:D001932 | Brain Neoplasms |  | Curcumin | 3.43 | 17596214 | 
| MESH:D001943 | Breast Neoplasms |  | Benzo(a)pyrene | 5.04 | 17474063	20146248 | 
| MESH:D001943 | Breast Neoplasms |  | bexarotene | 5.04 | 16344269	16818667 | 
| MESH:D001943 | Breast Neoplasms |  | Curcumin | 5.04 | 19250217	18462866	18593918	16243823 | 
| MESH:D001943 | Breast Neoplasms |  | Fluorouracil | 5.04 | 16110121	16595493	19217205	18357371	15136595	16557594	18608205 | 
| MESH:D001943 | Breast Neoplasms |  | ochratoxin A | 5.04 | 11921183 | 
| MESH:D001943 | Breast Neoplasms |  | Paclitaxel | 5.04 | 15136595	11325840	18323546	16115903	16273361	18223236	16244791	18234424 | 
| MESH:D001943 | Breast Neoplasms |  | Quercetin | 5.04 | 18628248 | 
| MESH:D001943 | Breast Neoplasms |  | resveratrol | 5.04 | 17534123	16393696	17651959 | 
| MESH:D001943 | Breast Neoplasms |  | Tetrachlorodibenzodioxin | 5.04 | 20435547 | 
| MESH:D016535 | Bronchial Hyperreactivity |  | Ozone | 3.21 | 18315731	14754758	17626835	15516495	18417511	16777450	19059883 | 
| MESH:D002100 | Cachexia |  | Ozone | 4.16 | 16183385 | 
| MESH:D002105 | Cadmium Poisoning |  | Quercetin | 4.95 | 16962696 | 
| MESH:D002252 | Carbon Tetrachloride Poisoning |  | Carbon Tetrachloride | 3.21 | 16050911	16227642	16011737	15673190	16192424	15700767	18705752	15721981	3786805	10355542	16097048	16124888 | 
| MESH:D002276 | Carcinoid Tumor |  | Fluorouracil | 4.07 | 16051944 | 
| MESH:D002277 | Carcinoma |  | Curcumin | 11.26 | 18593918 | 
| MESH:D002277 | Carcinoma |  | Fluorouracil | 11.26 | 17121937 | 
| MESH:D002277 | Carcinoma |  | Tetrachlorodibenzodioxin | 11.26 | 16835633 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,6-dinitrotoluene | 14.65 | 16705839 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Aflatoxin B1 | 14.65 | 12907637	12619106	21507988 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | anthra(1,9-cd)pyrazol-6(2H)-one | 14.65 | 19418558 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Carbon Tetrachloride | 14.65 | 18788625 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Fluorouracil | 14.65 | 17045692	18930000	16332177	17088986	16799960	17971768 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Paclitaxel | 14.65 | 16313753 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | Quercetin | 14.65 | 19519916	12508355 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | resveratrol | 14.65 | 19321006	16227395 | 
| MESH:D018827 | Carcinoma, Lewis Lung |  | resveratrol | 4.01 | 16675471 | 
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung |  | bexarotene | 5.05 | 16247446 | 
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung |  | Curcumin | 5.05 | 18414057 | 
| MESH:D021441 | Carcinoma, Pancreatic Ductal |  | Quercetin | 4.38 | 17234771 | 
| MESH:D002292 | Carcinoma, Renal Cell |  | Fluorouracil | 2.72 | 18695887 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Benzo(a)pyrene | 9.08 | 20419170 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Curcumin | 9.08 | 18462866 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | Fluorouracil | 9.08 | 17066447	16757204	18986760	16280240 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | resveratrol | 9.08 | 16227395 | 
| MESH:D006332 | Cardiomegaly |  | Quercetin | 5.63 | 19794523 | 
| MESH:D006332 | Cardiomegaly |  | Tetrachlorodibenzodioxin | 5.63 | 18670907	16120746	18850075 | 
| MESH:D009202 | Cardiomyopathies |  | Iron | 3.64 | 16640825 | 
| MESH:D002311 | Cardiomyopathy, Dilated |  | Amiodarone | 5.37 | 15710769	19225199 | 
| MESH:D002311 | Cardiomyopathy, Dilated |  | Iron | 5.37 | 16604332 | 
| MESH:D002318 | Cardiovascular Diseases |  | clopidogrel | 6.60 | 20180610 | 
| MESH:D002318 | Cardiovascular Diseases |  | resveratrol | 6.60 | 15458977 | 
| MESH:D020212 | Carotid Artery Injuries |  | bivalirudin | 6.02 | 11316950 | 
| MESH:D002341 | Carotid Artery Thrombosis |  | Amiodarone | 4.50 | 18974383 | 
| MESH:D002386 | Cataract |  | Adenosine Triphosphate | 7.31 | 15003327 | 
| MESH:D002386 | Cataract |  | Simvastatin | 7.31 | 12518039 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 2,6-dinitrotoluene | 5.19 | 6135515 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Cyclosporine | 5.19 | 12371664 | 
| MESH:D002543 | Cerebral Hemorrhage |  | Warfarin | 5.29 | 11061249 | 
| MESH:D018281 | Cholangiocarcinoma |  | Tetrachlorodibenzodioxin | 2.67 | 16835633 | 
| MESH:D002779 | Cholestasis |  | Cyclosporine | 6.30 | 19486331 | 
| MESH:D002779 | Cholestasis |  | Ethinyl Estradiol | 6.30 | 16919318	17110522	16105132	15861022	17681005	17333356	11677210 | 
| MESH:D002972 | Cleft Palate |  | Tetrachlorodibenzodioxin | 1.83 | 16354765	15340226	12621046	15668235	8697196 | 
| MESH:D003092 | Colitis |  | Curcumin | 7.91 | 16782535	16804969	18200517 | 
| MESH:D003092 | Colitis |  | resveratrol | 7.91 | 16474422 | 
| MESH:D003103 | Coloboma |  | Curcumin | 4.02 | 18809619 | 
| MESH:D003110 | Colonic Neoplasms |  | Curcumin | 12.16 | 16340194	19359593 | 
| MESH:D003110 | Colonic Neoplasms |  | Dexamethasone | 12.16 | 15824018 | 
| MESH:D003110 | Colonic Neoplasms |  | Fluorouracil | 12.16 | 17287894	17725105	17172411	15001691	16340194	16510598	17018589	17016597	18772588	17169374 | 
| MESH:D003110 | Colonic Neoplasms |  | Iron | 12.16 | 16640825 | 
| MESH:D003110 | Colonic Neoplasms |  | Quercetin | 12.16 | 11134977	16640504	17191121	19440933	19056647	15741050	17148506 | 
| MESH:D003110 | Colonic Neoplasms |  | resveratrol | 12.16 | 16338953 | 
| MESH:D015179 | Colorectal Neoplasms |  | Fluorouracil | 4.22 | 17454858	18949393	18802399	16391804	18383874	18288408	15148649	17016601	17695437	18448328	16282729	17401013	16303861	14970324	16524972	17255274	18509181	15289873	20501625	17594712	17094418	16331619 | 
| MESH:D015179 | Colorectal Neoplasms |  | Paclitaxel | 4.22 | 18802399 | 
| MESH:D015179 | Colorectal Neoplasms |  | Quercetin | 4.22 | 18852136	18095365 | 
| MESH:D015179 | Colorectal Neoplasms |  | resveratrol | 4.22 | 16550006 | 
| MESH:D000013 | Congenital Abnormalities |  | Tetrachlorodibenzodioxin | 2.57 | 17141729	14669216 | 
| MESH:D016510 | Corneal Neovascularization |  | Curcumin | 4.33 | 18497527 | 
| MESH:D003327 | Coronary Disease |  | resveratrol | 3.36 | 16507316 | 
| MESH:D023903 | Coronary Restenosis |  | Warfarin | 5.12 | 12872399 | 
| MESH:D003328 | Coronary Thrombosis |  | bivalirudin | 5.22 | 18036681 | 
| MESH:D003371 | Cough |  | Capsaicin | 4.58 | 10350223 | 
| OMIM:122700 | COUMARIN RESISTANCE |  | Warfarin | 5.28 | 20579077	20497562 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Dexamethasone | 3.52 | 17728286 | 
| MESH:D019465 | Craniofacial Abnormalities |  | ochratoxin A | 3.52 | 20036863 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Tetrachlorodibenzodioxin | 3.52 | 10048152	20055451	15322242 | 
| MESH:D003490 | Cyanosis |  | 2,6-dinitrotoluene | 3.45 | 18551238 | 
| MESH:D003550 | Cystic Fibrosis |  | Simvastatin | 4.44 | 19747007 | 
| MESH:D007644 | Darier Disease |  | Fluorouracil | 4.21 | 16733453 | 
| MESH:D003731 | Dental Caries |  | Aspartame | 6.33 | 8955999 | 
| MESH:D017449 | Dermatitis, Allergic Contact |  | Aspartame | 5.91 | 14996049 | 
| MESH:D017449 | Dermatitis, Allergic Contact |  | Dexamethasone | 5.91 | 12438553 | 
| MESH:D048909 | Diabetes Complications |  | bivalirudin | 5.76 | 18436116 | 
| MESH:D003920 | Diabetes Mellitus |  | Iron | 3.96 | 16640825	16604332 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | Quercetin | 6.96 | 19496084 | 
| MESH:D003921 | Diabetes Mellitus, Experimental |  | resveratrol | 6.96 | 16873680 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Iron | 5.55 | 16506275 | 
| MESH:D003922 | Diabetes Mellitus, Type 1 |  | Warfarin | 5.55 | 18772604 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Curcumin | 8.80 | 18403477 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | epigallocatechin gallate | 8.80 | 16988119 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Iron | 8.80 | 16506275 | 
| MESH:D003924 | Diabetes Mellitus, Type 2 |  | Tetrachlorodibenzodioxin | 8.80 | 17107852 | 
| MESH:D003928 | Diabetic Nephropathies |  | Curcumin | 12.46 | 18204486 | 
| MESH:D003928 | Diabetic Nephropathies |  | resveratrol | 12.46 | 16286809 | 
| MESH:D003928 | Diabetic Nephropathies |  | Warfarin | 12.46 | 12644472 | 
| MESH:D003967 | Diarrhea |  | Dexamethasone | 3.16 | 7237001 | 
| MESH:D003875 | Drug Eruptions |  | Warfarin | 5.41 | 14723717 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,6-dinitrotoluene | 7.22 | 18551238	21346803 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Amiodarone | 7.22 | 18218290	15265979 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Carbon Tetrachloride | 7.22 | 7179309	21278145	7120509	10915739	10092053	17522070	15998439	16227642	15027814	7440962	3786805	9327722	6884620	2869522	6623471	4309450	11566570	19085960	3732212	16177239	19336974	15968718 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Tetrachlorodibenzodioxin | 7.22 | 20420201 | 
| MESH:D004362 | Drug Toxicity |  | Tetrachlorodibenzodioxin | 2.32 | 11462148 | 
| MESH:D004381 | Duodenal Ulcer |  | Capsaicin | 7.79 | 11535926	10671773 | 
| MESH:D004381 | Duodenal Ulcer |  | Curcumin | 7.79 | 17351913 | 
| MESH:D004417 | Dyspnea |  | Chlorine | 4.03 | 20016425 | 
| MESH:D004485 | Eczema |  | Dexamethasone | 3.91 | 12438553 | 
| MESH:D004487 | Edema |  | Dexamethasone | 8.58 | 19703484 | 
| MESH:D004487 | Edema |  | resveratrol | 8.58 | 8985016 | 
| MESH:D004487 | Edema |  | Tetrachlorodibenzodioxin | 8.58 | 12711302	11000095 | 
| MESH:D004489 | Edema, Cardiac |  | Tetrachlorodibenzodioxin | 3.31 | 15322242	18230668	16714409 | 
| MESH:D016769 | Embolism and Thrombosis |  | argatroban | 26.77 | 16084352 | 
| MESH:D016769 | Embolism and Thrombosis |  | BCH 2763 | 26.77 | 9684808 | 
| MESH:D016769 | Embolism and Thrombosis |  | bivalirudin | 26.77 | 16084352 | 
| MESH:D016769 | Embolism and Thrombosis |  | melagatran | 26.77 | 16084352 | 
| MESH:D016769 | Embolism and Thrombosis |  | ximelagatran | 26.77 | 16084352 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Ethinyl Estradiol | 7.29 | 12538720 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | resveratrol | 7.29 | 17872969 | 
| MESH:D004715 | Endometriosis |  | Tetrachlorodibenzodioxin | 2.52 | 10568697	9294722 | 
| MESH:D020345 | Enterocolitis, Necrotizing |  | resveratrol | 4.28 | 17923197 | 
| MESH:D004893 | Erythema Nodosum |  | Aspartame | 6.33 | 9324739 | 
| MESH:D004935 | Esophageal Diseases |  | Capsaicin | 5.12 | 19566590 | 
| MESH:D004938 | Esophageal Neoplasms |  | Benzo(a)pyrene | 6.22 | 16530937 | 
| MESH:D004938 | Esophageal Neoplasms |  | Fluorouracil | 6.22 | 15173087	17638652	16337965	16785472	16481741 | 
| MESH:D004938 | Esophageal Neoplasms |  | Paclitaxel | 6.22 | 16481741 | 
| MESH:D005124 | Eye Abnormalities |  | Tetrachlorodibenzodioxin | 2.57 | 11564622 | 
| MESH:D005141 | Eyelid Diseases |  | Aspartame | 5.78 | 14996049 | 
| MESH:D005221 | Fatigue |  | Amphetamine | 5.02 | 19890266 | 
| MESH:D005234 | Fatty Liver |  | Amiodarone | 23.98 | 14986274 | 
| MESH:D005234 | Fatty Liver |  | Carbon Tetrachloride | 23.98 | 16045604	12631006	19224547	12795759	61145	15959796	17595544	16239168 | 
| MESH:D005234 | Fatty Liver |  | Curcumin | 23.98 | 19297423 | 
| MESH:D005234 | Fatty Liver |  | Cyclosporine | 23.98 | 19224547 | 
| MESH:D005234 | Fatty Liver |  | Ethinyl Estradiol | 23.98 | 15345470 | 
| MESH:D005234 | Fatty Liver |  | Iron | 23.98 | 16640825 | 
| MESH:D005313 | Fetal Death |  | Tetrachlorodibenzodioxin | 2.89 | 11858732 | 
| MESH:D005334 | Fever |  | Aspartame | 4.82 | 9630831 | 
| MESH:D005355 | Fibrosis |  | Carbon Tetrachloride | 21.74 | 18705752 | 
| MESH:D005355 | Fibrosis |  | Curcumin | 21.74 | 18705752 | 
| MESH:D005355 | Fibrosis |  | Cyclosporine | 21.74 | 12168785	12639820 | 
| MESH:D005355 | Fibrosis |  | Quercetin | 21.74 | 19474275 | 
| MESH:D005355 | Fibrosis |  | Tetrachlorodibenzodioxin | 21.74 | 20067830 | 
| MESH:D005621 | Friedreich Ataxia |  | Iron | 4.86 | 16604332	16640825 | 
| MESH:D005739 | Gas Poisoning |  | Chlorine | 4.42 | 20016425 | 
| MESH:D006471 | Gastrointestinal Hemorrhage |  | Warfarin | 6.12 | 11794436 | 
| MESH:D005770 | Gastrointestinal Neoplasms |  | Curcumin | 4.12 | 18462866 | 
| MESH:D005776 | Gaucher Disease |  | Warfarin | 5.40 | 12359135 | 
| MESH:D005885 | Gingival Hyperplasia |  | Cyclosporine | 3.63 | 8708960 | 
| MESH:D005909 | Glioblastoma |  | Capsaicin | 9.80 | 18405923 | 
| MESH:D005909 | Glioblastoma |  | Curcumin | 9.80 | 17596214 | 
| MESH:D005909 | Glioblastoma |  | Quercetin | 9.80 | 19804834 | 
| MESH:D005910 | Glioma |  | Fluorouracil | 5.29 | 16145905 | 
| MESH:D005910 | Glioma |  | Quercetin | 5.29 | 17643826 | 
| MESH:D006058 | Gonadal Disorders |  | Tetrachlorodibenzodioxin | 4.00 | 10696789 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Curcumin | 6.60 | 18462866	18829502 | 
| MESH:D006258 | Head and Neck Neoplasms |  | Fluorouracil | 6.60 | 15102660	18337622	15162350 | 
| MESH:D006356 | Heartburn |  | Capsaicin | 5.12 | 19566590 | 
| MESH:D006330 | Heart Defects, Congenital |  | Benzo(a)pyrene | 5.32 | 20471113 | 
| MESH:D006330 | Heart Defects, Congenital |  | Tetrachlorodibenzodioxin | 5.32 | 10048152	11294989 | 
| MESH:D006406 | Hematoma |  | Warfarin | 6.12 | 17493413 | 
| MESH:D006432 | Hemochromatosis |  | Iron | 4.05 | 17053826	16640825	16604332	16574947	17255318	17236123 | 
| MESH:D006457 | Hemoglobinuria, Paroxysmal |  | Cyclosporine | 3.84 | 15720958 | 
| MESH:D006470 | Hemorrhage |  | bivalirudin | 14.56 | 19147609	16125490	18436116	19281522	19360860	16598112 | 
| MESH:D006470 | Hemorrhage |  | Tetrachlorodibenzodioxin | 14.56 | 11000095 | 
| MESH:D006470 | Hemorrhage |  | Warfarin | 14.56 | 18429757 | 
| MESH:D006486 | Hemosiderosis |  | Iron | 4.62 | 16604332 | 
| MESH:D006505 | Hepatitis |  | Carbon Tetrachloride | 3.05 | 19900420	19110552 | 
| MESH:D006525 | Hepatitis, Viral, Human |  | Iron | 4.87 | 16640825 | 
| MESH:D006527 | Hepatolenticular Degeneration |  | Iron | 4.37 | 17182432 | 
| MESH:D006529 | Hepatomegaly |  | Amiodarone | 11.32 | 15265979 | 
| MESH:D006529 | Hepatomegaly |  | Iron | 11.32 | 16890145 | 
| MESH:D006529 | Hepatomegaly |  | Tetrachlorodibenzodioxin | 11.32 | 15340226	16120746	12621046 | 
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy |  | Curcumin | 4.47 | 17701891 | 
| MESH:D006548 | Hernia, Diaphragmatic |  | Dexamethasone | 2.84 | 7520565 | 
| MESH:D006561 | Herpes Simplex |  | resveratrol | 3.60 | 16876885 | 
| MESH:D015658 | HIV Infections |  | Iron | 3.34 | 16597321 | 
| MESH:D006869 | Hydronephrosis |  | Tetrachlorodibenzodioxin | 3.45 | 8697196	16959395	15340226	18606429	16354765 | 
| MESH:D006930 | Hyperalgesia |  | Capsaicin | 3.87 | 17434803	17043245 | 
| MESH:D006932 | Hyperbilirubinemia |  | Carbon Tetrachloride | 3.95 | 16899240 | 
| MESH:D006937 | Hypercholesterolemia |  | Amiodarone | 12.38 | 8137927	9751232 | 
| MESH:D006937 | Hypercholesterolemia |  | Curcumin | 12.38 | 18704882 | 
| MESH:D006937 | Hypercholesterolemia |  | resveratrol | 12.38 | 17188708 | 
| MESH:D006943 | Hyperglycemia |  | Quercetin | 3.52 | 11834736	18262572 | 
| MESH:D006948 | Hyperkinesis |  | Amphetamine | 4.85 | 14960337	1977408 | 
| MESH:D006949 | Hyperlipidemias |  | resveratrol | 3.49 | 16873680 | 
| MESH:D006938 | Hyperlipoproteinemia Type II |  | Simvastatin | 4.74 | 16238680 | 
| MESH:D006973 | Hypertension |  | Aspartame | 13.64 | 18708962 | 
| MESH:D006973 | Hypertension |  | Cyclosporine | 13.64 | 10903974 | 
| MESH:D006973 | Hypertension |  | Dexamethasone | 13.64 | 17042910 | 
| MESH:D006973 | Hypertension |  | Quercetin | 13.64 | 18356687 | 
| MESH:D006973 | Hypertension |  | Tetrachlorodibenzodioxin | 13.64 | 18850075	18670907 | 
| MESH:D006975 | Hypertension, Portal |  | Carbon Tetrachloride | 3.52 | 15338365 | 
| MESH:D006976 | Hypertension, Pulmonary |  | Warfarin | 4.38 | 12359135 | 
| MESH:D017379 | Hypertrophy, Left Ventricular |  | resveratrol | 3.79 | 17488730 | 
| MESH:D007006 | Hypogonadism |  | Iron | 3.98 | 16640825 | 
| MESH:D007020 | Hypoprothrombinemias | marker/mechanism |  |  |  | 
| MESH:D007021 | Hypospadias |  | Ethinyl Estradiol | 3.24 | 16945680	16569931 | 
| MESH:D007037 | Hypothyroidism |  | Amiodarone | 9.79 | 17991464	18020914 | 
| MESH:D007037 | Hypothyroidism |  | Iron | 9.79 | 16640825 | 
| MESH:D020244 | Infarction, Middle Cerebral Artery |  | resveratrol | 4.08 | 17600658 | 
| MESH:D007247 | Infertility, Female |  | Ethinyl Estradiol | 2.92 | 12013081 | 
| MESH:D007248 | Infertility, Male |  | Ethinyl Estradiol | 2.09 | 17937319 | 
| MESH:D007249 | Inflammation |  | bivalirudin | 15.64 | 16125490 | 
| MESH:D007249 | Inflammation |  | Capsaicin | 15.64 | 16956363 | 
| MESH:D007249 | Inflammation |  | Curcumin | 15.64 | 18403477	16956363	17151092 | 
| MESH:D007249 | Inflammation |  | Dexamethasone | 15.64 | 11099482	8960868 | 
| MESH:D007249 | Inflammation |  | resveratrol | 15.64 | 16366677 | 
| MESH:D007249 | Inflammation |  | Tetrachlorodibenzodioxin | 15.64 | 12200463	12878042 | 
| MESH:D015212 | Inflammatory Bowel Diseases |  | Curcumin | 2.94 | 18596194	18200517 | 
| MESH:D007251 | Influenza, Human |  | Quercetin | 9.22 | 16624496 | 
| MESH:D007251 | Influenza, Human |  | resveratrol | 9.22 | 16624496 | 
| MESH:D007414 | Intestinal Neoplasms |  | Curcumin | 3.71 | 10783313 | 
| MESH:D019189 | Iron Metabolism Disorders |  | Iron | 4.50 | 17163184 | 
| MESH:D007511 | Ischemia |  | bivalirudin | 5.45 | 18436116 | 
| MESH:D007569 | Jaw Abnormalities |  | Tetrachlorodibenzodioxin | 2.81 | 16580747 | 
| MESH:D007627 | Keloid |  | Quercetin | 4.38 | 17086741 | 
| MESH:D007638 | Keratoconjunctivitis Sicca |  | Cyclosporine | 3.85 | 15604871 | 
| MESH:D007674 | Kidney Diseases |  | Aspartame | 11.63 | 11409539 | 
| MESH:D007674 | Kidney Diseases |  | Cyclosporine | 11.63 | 10903974	18776723	8314463 | 
| MESH:D007674 | Kidney Diseases |  | ochratoxin A | 11.63 | 11409539 | 
| MESH:D007674 | Kidney Diseases |  | Quercetin | 11.63 | 16962696 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,6-dinitrotoluene | 13.91 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | Cyclosporine | 13.91 | 12371664 | 
| MESH:D007680 | Kidney Neoplasms |  | Fluorouracil | 13.91 | 16985049 | 
| MESH:D007680 | Kidney Neoplasms |  | ochratoxin A | 13.91 | 16251485 | 
| MESH:D007889 | Leiomyoma |  | Curcumin | 4.03 | 18555241 | 
| MESH:D007938 | Leukemia |  | Curcumin | 5.56 | 18462866 | 
| MESH:D007938 | Leukemia |  | Quercetin | 5.56 | 17468513 | 
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell |  | Curcumin | 3.68 | 16106398 | 
| MESH:D007948 | Leukemia, Monocytic, Acute |  | anthra(1,9-cd)pyrazol-6(2H)-one | 4.79 | 16972261 | 
| MESH:D015473 | Leukemia, Promyelocytic, Acute |  | resveratrol | 3.18 | 16087638 | 
| MESH:D015458 | Leukemia, T-Cell |  | Curcumin | 4.21 | 16106398 | 
| MESH:D020961 | Lewy Body Disease |  | Iron | 4.86 | 16563566 | 
| MESH:D008064 | Lipidoses |  | Amiodarone | 3.08 | 15342952	17567588 | 
| MESH:D008080 | Liposarcoma |  | Paclitaxel | 4.28 | 17353645 | 
| MESH:D054068 | Livedo Reticularis |  | Warfarin | 6.12 | 18280355 | 
| MESH:D008103 | Liver Cirrhosis |  | Carbon Tetrachloride | 5.78 | 16943688	17157831	11408273	21278145	11903743	16221502	17174718	17334410	16239168 | 
| MESH:D008103 | Liver Cirrhosis |  | Iron | 5.78 | 16640825 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Carbon Tetrachloride | 9.37 | 18006644	11481614	18277467	17900296	17922224	15052691	15925388	18472332	18054572	16097048	12632514	14716833	12445418	18418968	18251166	15650968	16015684	16027843	18376398	12667390	17805973	12958196	15730626	14724832	15931870	12609069	15338365	18395095	17708605	15123356	17714472	12445421	16248980	17640975	14716496	15362042	17761835	17766677	15673190	15959796	14512876	18317297	15370692	20821823	12666154	16192424	17823541	18187930	16638106	17565644	18210741	18420326	17698563	17481882	12389079	18339082	14620537	12586293	12546737	16116963	18395914	18481824	17557913	18429990	17721639	17944888	12898905	15893842	18279442	12741479	18412020	12632512	15818738	15996030	10355542	16011737	13678700	16136751	18205269	18705752	17869086	12649538	17525996	18472094	16033810	18263696	18166357	17976157	15057751	18156304	14748882	15876570	17631135 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Curcumin | 9.37 | 17355460	18705752	18006644 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Dexamethasone | 9.37 | 16718785 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | epigallocatechin gallate | 9.37 | 17481882 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Heparin | 9.37 | 16904936 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Quercetin | 9.37 | 12741479 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Tetrachlorodibenzodioxin | 9.37 | 12878042 | 
| MESH:D008107 | Liver Diseases |  | Capsaicin | 5.65 | 16956363 | 
| MESH:D008107 | Liver Diseases |  | Carbon Tetrachloride | 5.65 | 17285989	15720792	16246199	16964402	15830285 | 
| MESH:D008107 | Liver Diseases |  | Curcumin | 5.65 | 16956363 | 
| MESH:D008108 | Liver Diseases, Alcoholic |  | Iron | 4.44 | 17207112	16737972 | 
| MESH:D017093 | Liver Failure |  | Carbon Tetrachloride | 3.59 | 15123358 | 
| MESH:D017114 | Liver Failure, Acute |  | Carbon Tetrachloride | 3.18 | 14706259	16899240 | 
| MESH:D008113 | Liver Neoplasms |  | 2,6-dinitrotoluene | 24.94 | 7678174 | 
| MESH:D008113 | Liver Neoplasms |  | Aflatoxin B1 | 24.94 | 2125692	15890375	9163691	18177683 | 
| MESH:D008113 | Liver Neoplasms |  | Benzo(a)pyrene | 24.94 | 21137059	20195826 | 
| MESH:D008113 | Liver Neoplasms |  | Carbon Tetrachloride | 24.94 | 19294768 | 
| MESH:D008113 | Liver Neoplasms |  | Fluorouracil | 24.94 | 16603448	17045692	15113037	18383874 | 
| MESH:D008113 | Liver Neoplasms |  | Iron | 24.94 | 20302851	16640825 | 
| MESH:D008113 | Liver Neoplasms |  | Quercetin | 24.94 | 18980244 | 
| MESH:D008113 | Liver Neoplasms |  | resveratrol | 24.94 | 19073162	19812893	20405173	19321006 | 
| MESH:D008113 | Liver Neoplasms |  | Tetrachlorodibenzodioxin | 24.94 | 16984957 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | 2,6-dinitrotoluene | 14.55 | 6135515	2876786	2876784 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Aflatoxin B1 | 14.55 | 8603461 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Carbon Tetrachloride | 14.55 | 12014681	15583823 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Quercetin | 14.55 | 19519916 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | Tetrachlorodibenzodioxin | 14.55 | 12151625 | 
| MESH:D008133 | Long QT Syndrome |  | Amiodarone | 3.13 | 17391786	11989578	15350150 | 
| MESH:D008171 | Lung Diseases |  | Amiodarone | 6.23 | 12587719 | 
| MESH:D008171 | Lung Diseases |  | Ozone | 6.23 | 8266340	19066396 | 
| MESH:D017563 | Lung Diseases, Interstitial |  | Amiodarone | 3.89 | 18516814 | 
| MESH:D055370 | Lung Injury |  | Ozone | 3.29 | 20417186 | 
| MESH:D008175 | Lung Neoplasms |  | Aflatoxin B1 | 15.68 | 14755239 | 
| MESH:D008175 | Lung Neoplasms |  | Benzo(a)pyrene | 15.68 | 18520028	6695378	20464547	20064080	18569708	20135361	18816296	20869020	17053015 | 
| MESH:D008175 | Lung Neoplasms |  | bexarotene | 15.68 | 17849452 | 
| MESH:D008175 | Lung Neoplasms |  | Curcumin | 15.68 | 19359593	18462866	16243823 | 
| MESH:D008175 | Lung Neoplasms |  | Dexamethasone | 15.68 | 15824018	11195469 | 
| MESH:D008175 | Lung Neoplasms |  | Fluorouracil | 15.68 | 15246190 | 
| MESH:D008175 | Lung Neoplasms |  | Iron | 15.68 | 16640825 | 
| MESH:D008175 | Lung Neoplasms |  | Ozone | 15.68 | 7614698	8597069 | 
| MESH:D008175 | Lung Neoplasms |  | Quercetin | 15.68 | 16280456 | 
| MESH:D008175 | Lung Neoplasms |  | Tetrachlorodibenzodioxin | 15.68 | 19555203	11884234 | 
| MESH:D008178 | Lupus Erythematosus, Cutaneous |  | Fluorouracil | 4.21 | 15086387 | 
| MESH:D008223 | Lymphoma |  | Curcumin | 3.16 | 18462866 | 
| MESH:D016393 | Lymphoma, B-Cell |  | resveratrol | 3.76 | 17088997 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | Paclitaxel | 7.39 | 14749477 | 
| MESH:D008228 | Lymphoma, Non-Hodgkin |  | resveratrol | 7.39 | 14749477 | 
| MESH:D016399 | Lymphoma, T-Cell |  | Curcumin | 4.12 | 16173963 | 
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous |  | bexarotene | 4.58 | 11161223 | 
| MESH:D008268 | Macular Degeneration |  | Iron | 3.63 | 16640825 | 
| MESH:D015674 | Mammary Neoplasms, Animal |  | resveratrol | 3.67 | 15688416 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | bexarotene | 8.03 | 19196722	19196723	15591091 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | ochratoxin A | 8.03 | 11921183 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | resveratrol | 8.03 | 8985016	11606380 | 
| MESH:D008545 | Melanoma |  | Curcumin | 6.26 | 17885582	18462866 | 
| MESH:D008545 | Melanoma |  | epigallocatechin gallate | 6.26 | 11746506	17992120 | 
| MESH:D008545 | Melanoma |  | Paclitaxel | 6.26 | 16342250	12025231	12040289 | 
| MESH:D008545 | Melanoma |  | resveratrol | 6.26 | 17992120 | 
| MESH:D008569 | Memory Disorders |  | Curcumin | 3.60 | 17263510 | 
| MESH:D008659 | Metabolic Diseases |  | resveratrol | 3.85 | 17112576 | 
| MESH:D008664 | Metal Metabolism, Inborn Errors |  | Cyclosporine | 4.19 | 16801185 | 
| MESH:D008679 | Metaplasia |  | Ozone | 4.51 | 10496685 | 
| MESH:D008850 | Microphthalmos |  | ochratoxin A | 5.24 | 20036863 | 
| MESH:D008881 | Migraine Disorders |  | Aspartame | 4.46 | 18627677	10792367 | 
| MESH:D009062 | Mouth Neoplasms |  | Benzo(a)pyrene | 7.01 | 16381670 | 
| MESH:D009062 | Mouth Neoplasms |  | Fluorouracil | 7.01 | 16757204	18986760 | 
| MESH:D009101 | Multiple Myeloma |  | Capsaicin | 18.15 | 17505005 | 
| MESH:D009101 | Multiple Myeloma |  | Curcumin | 18.15 | 19372569 | 
| MESH:D009101 | Multiple Myeloma |  | Dexamethasone | 18.15 | 15744524	15867202	16118317 | 
| MESH:D009101 | Multiple Myeloma |  | Paclitaxel | 18.15 | 14749477 | 
| MESH:D009101 | Multiple Myeloma |  | resveratrol | 18.15 | 14749477	17164350	16267019	16490592	17935668	17049120 | 
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive |  | Iron | 5.08 | 17086897 | 
| MESH:D009134 | Muscular Atrophy, Spinal |  | Curcumin | 17.78 | 17962980 | 
| MESH:D009134 | Muscular Atrophy, Spinal |  | epigallocatechin gallate | 17.78 | 17962980 | 
| MESH:D009134 | Muscular Atrophy, Spinal |  | resveratrol | 17.78 | 17962980 | 
| MESH:D009181 | Mycoses |  | Amiodarone | 11.16 | 17974566	12754197 | 
| MESH:D009181 | Mycoses |  | Iron | 11.16 | 16640825 | 
| MESH:D009190 | Myelodysplastic Syndromes |  | Dexamethasone | 3.18 | 9809623 | 
| MESH:D009203 | Myocardial Infarction |  | Quercetin | 5.12 | 19595682 | 
| MESH:D009203 | Myocardial Infarction |  | resveratrol | 5.12 | 17188708	16456233	16525036	16317513	17125593	17015251 | 
| MESH:D017202 | Myocardial Ischemia |  | bivalirudin | 18.09 | 10562259 | 
| MESH:D017202 | Myocardial Ischemia |  | Iron | 18.09 | 16604332 | 
| MESH:D017202 | Myocardial Ischemia |  | resveratrol | 18.09 | 17125593	17015251 | 
| MESH:D017202 | Myocardial Ischemia |  | Tetrachlorodibenzodioxin | 18.09 | 12213967 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | Iron | 7.41 | 16604332 | 
| MESH:D015428 | Myocardial Reperfusion Injury |  | Quercetin | 7.41 | 19207477 | 
| MESH:D009205 | Myocarditis |  | resveratrol | 4.18 | 17322642 | 
| MESH:D009336 | Necrosis |  | 2,6-dinitrotoluene | 9.03 | 7678174	18551238 | 
| MESH:D009336 | Necrosis |  | Warfarin | 9.03 | 14723717 | 
| MESH:D009361 | Neoplasm Invasiveness |  | Curcumin | 3.82 | 18495463 | 
| MESH:D009362 | Neoplasm Metastasis |  | clopidogrel | 5.68 | 11875746 | 
| MESH:D009362 | Neoplasm Metastasis |  | Paclitaxel | 5.68 | 15867366 | 
| MESH:D009369 | Neoplasms |  | Aspartame | 9.33 | 16507461 | 
| MESH:D009369 | Neoplasms |  | Benzo(a)pyrene | 9.33 | 11141357 | 
| MESH:D009369 | Neoplasms |  | Fluorouracil | 9.33 | 18239605	18600527	16928823 | 
| MESH:D009369 | Neoplasms |  | Quercetin | 9.33 | 15185748 | 
| MESH:D009374 | Neoplasms, Experimental |  | resveratrol | 3.44 | 8985016 | 
| MESH:D009376 | Neoplasms, Hormone-Dependent |  | bexarotene | 9.16 | 19196722 | 
| MESH:D009376 | Neoplasms, Hormone-Dependent |  | Curcumin | 9.16 | 12497104 | 
| MESH:D009402 | Nephrosis, Lipoid |  | Cyclosporine | 3.85 | 17954296 | 
| MESH:D009404 | Nephrotic Syndrome |  | Cyclosporine | 7.84 | 19348381	18481113 | 
| MESH:D009404 | Nephrotic Syndrome |  | Iron | 7.84 | 17178036 | 
| MESH:D009421 | Nervous System Malformations |  | Tetrachlorodibenzodioxin | 2.66 | 14600291 | 
| MESH:D009423 | Nervous System Neoplasms |  | Curcumin | 5.03 | 18462866 | 
| MESH:D009436 | Neural Tube Defects |  | ochratoxin A | 4.05 | 20036863 | 
| MESH:D019636 | Neurodegenerative Diseases |  | Amphetamine | 11.64 | 15183010 | 
| MESH:D019636 | Neurodegenerative Diseases |  | Iron | 11.64 | 17296847	16604332 | 
| MESH:D019636 | Neurodegenerative Diseases |  | resveratrol | 11.64 | 17652729 | 
| MESH:D020078 | Neurogenic Inflammation |  | Capsaicin | 14.80 | 17961222 | 
| MESH:D020078 | Neurogenic Inflammation |  | Quercetin | 14.80 | 17929310 | 
| MESH:D020078 | Neurogenic Inflammation |  | resveratrol | 14.80 | 17929310 | 
| MESH:D020258 | Neurotoxicity Syndromes |  | Fluorouracil | 3.03 | 16436463 | 
| MESH:D009765 | Obesity |  | Capsaicin | 4.57 | 19056576 | 
| MESH:D009765 | Obesity |  | Curcumin | 4.57 | 19297423 | 
| MESH:D009784 | Occupational Diseases |  | 2,6-dinitrotoluene | 2.93 | 16049721 | 
| MESH:D010003 | Osteoarthritis |  | Aspartame | 7.17 | 9630831 | 
| MESH:D010003 | Osteoarthritis |  | Iron | 7.17 | 16640825 | 
| MESH:D010014 | Osteolysis |  | Paclitaxel | 4.40 | 15867366 | 
| MESH:D010024 | Osteoporosis |  | Curcumin | 6.31 | 18719352 | 
| MESH:D010024 | Osteoporosis |  | Iron | 6.31 | 16640825	16648989 | 
| MESH:D015663 | Osteoporosis, Postmenopausal |  | Quercetin | 8.41 | 19495926 | 
| MESH:D015663 | Osteoporosis, Postmenopausal |  | resveratrol | 8.41 | 17513867 | 
| MESH:D010051 | Ovarian Neoplasms |  | Curcumin | 9.58 | 18462866	19020741 | 
| MESH:D010051 | Ovarian Neoplasms |  | Medroxyprogesterone Acetate | 9.58 | 17393432 | 
| MESH:D010051 | Ovarian Neoplasms |  | Paclitaxel | 9.58 | 11161223 | 
| MESH:D010051 | Ovarian Neoplasms |  | Quercetin | 9.58 | 19005980 | 
| MESH:D010146 | Pain |  | Aspartame | 6.27 | 9630831 | 
| MESH:D010146 | Pain |  | Capsaicin | 6.27 | 17084039	16996476	17043245	17434803	19081190	18987195 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Curcumin | 7.30 | 17440100	19196508	19401701 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Fluorouracil | 7.30 | 16929163	15113037	19003803	16500647 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Quercetin | 7.30 | 16965848 | 
| MESH:D016584 | Panic Disorder |  | Ethinyl Estradiol | 3.15 | 11578682 | 
| MESH:D010212 | Papilloma |  | Iron | 3.92 | 12065085 | 
| MESH:D020447 | Parasomnias |  | Iron | 5.42 | 17352947 | 
| MESH:D010300 | Parkinson Disease |  | Iron | 3.08 | 16563566	16640825 | 
| MESH:D010382 | Peliosis Hepatis |  | Tetrachlorodibenzodioxin | 3.65 | 12520081 | 
| MESH:D010538 | Peritonitis |  | Ozone | 3.57 | 16369182 | 
| MESH:D010900 | Pituitary Diseases |  | Iron | 5.08 | 16604332 | 
| MESH:D011014 | Pneumonia |  | Ozone | 3.81 | 18929643	18007984	18381685 | 
| MESH:D011041 | Poisoning |  | Iron | 3.76 | 16604332 | 
| MESH:D011085 | Polycystic Ovary Syndrome |  | Simvastatin | 4.83 | 17105841 | 
| MESH:D017119 | Porphyria Cutanea Tarda |  | Iron | 9.18 | 16640825 | 
| MESH:D017119 | Porphyria Cutanea Tarda |  | Tetrachlorodibenzodioxin | 9.18 | 18163543 | 
| MESH:D011230 | Precancerous Conditions |  | Cyclosporine | 7.46 | 12371664 | 
| MESH:D011230 | Precancerous Conditions |  | Quercetin | 7.46 | 19056647 | 
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |  | Dexamethasone | 3.19 | 21297632 | 
| MESH:D011225 | Pre-Eclampsia |  | Iron | 3.97 | 16640825 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | resveratrol | 7.66 | 16679765 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | Tetrachlorodibenzodioxin | 7.66 | 11222880	11118676	11399792	11896295 | 
| MESH:D011471 | Prostatic Neoplasms |  | Benzo(a)pyrene | 1.88 | 17292933 | 
| MESH:D011471 | Prostatic Neoplasms |  | Curcumin | 1.88 | 11398177	18226269	15129424	12497104	18156803	10851300	18769126 | 
| MESH:D011471 | Prostatic Neoplasms |  | Fluorouracil | 1.88 | 18626508	19082440 | 
| MESH:D011471 | Prostatic Neoplasms |  | Paclitaxel | 1.88 | 16356831	17172428	17136230	16729912 | 
| MESH:D011471 | Prostatic Neoplasms |  | Quercetin | 1.88 | 17292933	14715546 | 
| MESH:D011471 | Prostatic Neoplasms |  | resveratrol | 1.88 | 16731767	15767336	17675339	17718901	17636462	17804756 | 
| MESH:D020151 | Protein C Deficiency |  | Warfarin | 5.76 | 18376272 | 
| MESH:D011528 | Protozoan Infections |  | Iron | 5.42 | 16640825 | 
| MESH:D011537 | Pruritus |  | Ethinyl Estradiol | 2.74 | 15861022	16919318 | 
| MESH:D011565 | Psoriasis |  | Cyclosporine | 2.00 | 16882103 | 
| MESH:D011655 | Pulmonary Embolism |  | Warfarin | 5.76 | 19300499 | 
| MESH:D011656 | Pulmonary Emphysema |  | Curcumin | 4.02 | 19168576 | 
| MESH:D011658 | Pulmonary Fibrosis |  | Amiodarone | 2.60 | 11597910	12832656	12490602 | 
| MESH:D012004 | Rectal Neoplasms |  | Fluorouracil | 3.51 | 18286688	15538739	18722050	16160472 | 
| MESH:D051436 | Renal Insufficiency, Chronic |  | resveratrol | 4.99 | 16325855 | 
| MESH:D015427 | Reperfusion Injury |  | Capsaicin | 6.09 | 18460982	19211983 | 
| MESH:D015427 | Reperfusion Injury |  | resveratrol | 6.09 | 16314181	17520802	16317513	17058453	15827377 | 
| MESH:D012120 | Respiration Disorders |  | Chlorine | 4.62 | 18579056 | 
| MESH:D012128 | Respiratory Distress Syndrome, Adult |  | Curcumin | 7.52 | 18379247	10666014 | 
| MESH:D012128 | Respiratory Distress Syndrome, Adult |  | Dexamethasone | 7.52 | 11700416	18379247 | 
| MESH:D015619 | Respiratory System Abnormalities |  | Tetrachlorodibenzodioxin | 3.28 | 18990726 | 
| MESH:D012148 | Restless Legs Syndrome |  | Iron | 4.10 | 16930377 | 
| MESH:D012170 | Retinal Vein Occlusion |  | clopidogrel | 5.55 | 19371211 | 
| MESH:D012509 | Sarcoma |  | Curcumin | 3.61 | 18462866 | 
| MESH:D012554 | Schistosomiasis japonica |  | Quercetin | 4.95 | 16862918 | 
| MESH:D012640 | Seizures |  | 2,6-dinitrotoluene | 2.15 | 18551238 | 
| MESH:D018805 | Sepsis |  | Curcumin | 3.59 | 18389075 | 
| OMIM:609620 | SHORT QT SYNDROME 1 |  | Amiodarone | 4.50 | 18724381 | 
| MESH:D012851 | Sinus Thrombosis, Intracranial | marker/mechanism |  |  | 12269725 | 
| MESH:D012851 | Sinus Thrombosis, Intracranial |  | Heparin | 10.91 | 12269725 | 
| MESH:D012851 | Sinus Thrombosis, Intracranial |  | Warfarin | 10.91 | 12269725 | 
| MESH:D012859 | Sjogren's Syndrome |  | Aspartame | 5.98 | 16800424 | 
| MESH:D017445 | Skin Diseases, Vascular | marker/mechanism |  |  | 17535202 | 
| MESH:D012878 | Skin Neoplasms |  | Benzo(a)pyrene | 11.05 | 10029692	19755658 | 
| MESH:D012878 | Skin Neoplasms |  | Iron | 11.05 | 12065085 | 
| MESH:D012878 | Skin Neoplasms |  | resveratrol | 11.05 | 8985016	15837718 | 
| MESH:D012878 | Skin Neoplasms |  | Tetrachlorodibenzodioxin | 11.05 | 16192470 | 
| MESH:D013088 | Spermatocele |  | Ethinyl Estradiol | 3.35 | 16709447 | 
| MESH:D019956 | Stereotypic Movement Disorder |  | Amphetamine | 5.83 | 1977408 | 
| MESH:D013272 | Stomach Diseases |  | Dexamethasone | 3.74 | 15472012 | 
| MESH:D013274 | Stomach Neoplasms |  | Benzo(a)pyrene | 3.03 | 2093021	20155912 | 
| MESH:D013274 | Stomach Neoplasms |  | Fluorouracil | 3.03 | 16424979	19084572	18396642	17498489	17522103	16951190	18567086	19015929	17172411	15786421 | 
| MESH:D013274 | Stomach Neoplasms |  | Paclitaxel | 3.03 | 18506536	18396642 | 
| MESH:D013276 | Stomach Ulcer |  | Amiodarone | 9.17 | 18087811 | 
| MESH:D013276 | Stomach Ulcer |  | Curcumin | 9.17 | 16631530	19188055 | 
| MESH:D013276 | Stomach Ulcer |  | Dexamethasone | 9.17 | 15138204 | 
| MESH:D020521 | Stroke | marker/mechanism |  |  |  | 
| MESH:D020521 | Stroke |  | bivalirudin | 8.28 | 14683561 | 
| MESH:D020521 | Stroke |  | Warfarin | 8.28 | 19300499 | 
| OMIM:601367 | STROKE, ISCHEMIC | marker/mechanism |  |  |  | 
| OMIM:601367 | STROKE, ISCHEMIC |  | resveratrol | 3.97 | 16321402 | 
| MESH:D013398 | Sudden Infant Death |  | Iron | 4.87 | 16640825 | 
| MESH:D013610 | Tachycardia |  | Amiodarone | 3.74 | 11238279 | 
| MESH:D017180 | Tachycardia, Ventricular |  | Amiodarone | 3.64 | 19225199 | 
| MESH:D024801 | Tauopathies |  | Paclitaxel | 4.23 | 16930453 | 
| MESH:D013705 | Temporomandibular Joint Disorders |  | Capsaicin | 5.13 | 17997062 | 
| MESH:D013921 | Thrombocytopenia |  | argatroban | 19.14 | 16893407 | 
| MESH:D013921 | Thrombocytopenia |  | Aspartame | 19.14 | 17534100 | 
| MESH:D013921 | Thrombocytopenia |  | bivalirudin | 19.14 | 16651880	16893407 | 
| MESH:D013921 | Thrombocytopenia |  | Heparin | 19.14 | 16893407	16651880 | 
| MESH:D013923 | Thromboembolism |  | Warfarin | 5.57 | 18698879	16960144 | 
| MESH:D019851 | Thrombophilia | marker/mechanism |  |  |  | 
| MESH:D019851 | Thrombophilia |  | Ethinyl Estradiol | 15.33 | 11994571 | 
| MESH:D019851 | Thrombophilia |  | Gestodene | 15.33 | 11994571 | 
| MESH:D019851 | Thrombophilia |  | Warfarin | 15.33 | 17493413 | 
| MESH:D013927 | Thrombosis | marker/mechanism |  |  | 17245631 | 
| MESH:D013927 | Thrombosis |  | argatroban | 34.93 | 14593979	16893407 | 
| MESH:D013927 | Thrombosis |  | bivalirudin | 34.93 | 8456428	16893407	15979436	9125671	14593979 | 
| MESH:D013927 | Thrombosis |  | Ethinyl Estradiol | 34.93 | 15669648 | 
| MESH:D013927 | Thrombosis |  | Gestodene | 34.93 | 15669648 | 
| MESH:D013927 | Thrombosis |  | Heparin | 34.93 | 16893407 | 
| MESH:D013927 | Thrombosis |  | lepirudin | 34.93 | 14593979 | 
| MESH:D013927 | Thrombosis |  | Warfarin | 34.93 | 19300499	11518727	17672075	17245631	11307788	15720958 | 
| MESH:D013959 | Thyroid Diseases |  | Amiodarone | 10.07 | 19731979 | 
| MESH:D013959 | Thyroid Diseases |  | Tetrachlorodibenzodioxin | 10.07 | 12697716 | 
| MESH:D013971 | Thyrotoxicosis |  | Amiodarone | 4.29 | 18020914	19584973 | 
| MESH:D014062 | Tongue Neoplasms |  | Fluorouracil | 8.29 | 16280240 | 
| MESH:D014062 | Tongue Neoplasms |  | resveratrol | 8.29 | 16227395 | 
| MESH:D016171 | Torsades de Pointes |  | Amiodarone | 3.61 | 17467628	11989578 | 
| MESH:D014376 | Tuberculosis |  | Iron | 3.70 | 16597321 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,6-dinitrotoluene | 9.75 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Benzo(a)pyrene | 9.75 | 17053015 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Curcumin | 9.75 | 18593936 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | Quercetin | 9.75 | 16720314 | 
| MESH:D014565 | Urogenital Neoplasms |  | Curcumin | 4.68 | 18462866 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,6-dinitrotoluene | 3.73 | 10091137 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | Fluorouracil | 7.92 | 16803524 | 
| MESH:D002583 | Uterine Cervical Neoplasms |  | resveratrol | 7.92 | 17473185 | 
| MESH:D014594 | Uterine Neoplasms |  | Ethinyl Estradiol | 7.66 | 14692618 | 
| MESH:D014594 | Uterine Neoplasms |  | resveratrol | 7.66 | 17044934 | 
| MESH:D014605 | Uveitis |  | Cyclosporine | 9.79 | 1336536 | 
| MESH:D014605 | Uveitis |  | Dexamethasone | 9.79 | 1336536 | 
| MESH:D054079 | Vascular Malformations |  | Tetrachlorodibenzodioxin | 4.00 | 12125929 | 
| MESH:D014657 | Vasculitis |  | Heparin | 10.91 | 20337814 | 
| MESH:D014657 | Vasculitis |  | Warfarin | 10.91 | 20337814 | 
| MESH:D054556 | Venous Thromboembolism |  | Warfarin | 5.77 | 18776969 | 
| MESH:D020246 | Venous Thrombosis | marker/mechanism |  |  | 12296757	19920886 | 
| MESH:D020246 | Venous Thrombosis |  | Ethinyl Estradiol | 9.00 | 14671159	15869587 | 
| MESH:D020246 | Venous Thrombosis |  | Warfarin | 9.00 | 14723717	15733061 | 
| MESH:D018487 | Ventricular Dysfunction, Left |  | resveratrol | 3.73 | 17488730 | 
| MESH:D019282 | Wasting Syndrome |  | Tetrachlorodibenzodioxin | 3.65 | 15886252 | 
| MESH:D014985 | Xerophthalmia |  | Cyclosporine | 3.85 | 17120751 |